BiotechTube
DSI InPharmatics

DSI InPharmatics

Cambridge, United States· Est.
dsinpharmatics.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Founded in 2007 and headquartered in Cambridge, Massachusetts, DSI InPharmatics is a private, revenue-generating services firm that acts as a deep CMC and regulatory affairs consultancy for healthcare product companies. It leverages a team of seasoned professionals with extensive industry and FDA experience to guide clients through complex development and approval pathways, aiming to reduce time and cost. The company serves a broad range of therapeutic areas and product types, offering end-to-end support from early development to commercial manufacturing compliance.

OncologyCardiovascular DiseaseMetabolic DisordersNeurology

Technology Platform

Proprietary consultancy methodologies and intellectual capital in CMC (Chemistry, Manufacturing, Controls) and regulatory strategy, applied by a team of seasoned professionals with direct industry and FDA experience.

Opportunities

The growing complexity of drug development, especially for advanced therapies like cell and gene treatments, creates sustained demand for deep CMC expertise.
The rise of virtual and small biotechs, which lack internal regulatory teams, provides a large and expanding client base for outsourced services.

Risk Factors

High dependence on key personnel and client relationships; intense competition from both large CROs and boutique consultancies; vulnerability to downturns in biotech funding which reduce outsourced spending; and significant reputational risk if client projects face major regulatory setbacks.

Competitive Landscape

DSI competes in the fragmented regulatory and CMC consulting market against large, full-service Contract Research Organizations (CROs) and numerous small, specialized boutique firms. Its differentiation is its deep, phase-appropriate CMC focus, senior-level consultant experience, and positioning as a strategic partner rather than a transactional vendor.

More companies in Digital Health & Biotech SaaS →More companies in United States →